IRF4 and Miyoshi myopathy: Aside from aberrant overexpression, common genetic mutations in the DNA-binding domain of IRF4 have been reported in MM and ATL cells [55,56,87] and are thought to provide IRF4 with stronger transcriptional activity in the nucleus [97].